Baxter International Inc.

BAX

$17.60

+0.06% (+$0.01)

Chart by TradingView — for analysis only.

Key Statistics

Market Cap

P/E Ratio

Forward P/E

EPS

Dividend Yield

52W High

$32.68

52W Low

$15.73

Avg Volume

6.2M

Sector

Healthcare

Industry

Medical Instruments & Supplies

Some fundamental metrics are unavailable; 52-week range and average volume may still come from live quotes.

About Baxter International Inc.

Baxter International Inc. is a multinational healthcare company headquartered in Deerfield, Illinois, founded in 1931. It provides a broad portfolio of essential medical products and therapies focused on treating chronic and acute conditions in hospital and renal care settings. The company operates through key segments including Medical Products and Therapies, which encompass advanced surgery technologies to enhance surgical techniques, infusion therapies with sterile intravenous solutions, infusion systems and devices, and parenteral nutrition; Healthcare Systems and Technologies, offering smart bed systems, patient monitoring and diagnostic tools, respiratory health devices, and surgical equipment; and Pharmaceuticals, producing inhaled anesthetics and generic injectable pharmaceuticals for pain management, critical care, anti-infection, and oncology. These offerings support acute care, nutritional support, and surgical interventions worldwide, serving healthcare providers with innovative solutions for patient care across Americas, EMEA, and Asia-Pacific regions. Baxter International Inc. plays a vital role in advancing hospital-based care and connectivity solutions.

Company website →

Earnings

Next Earnings
2026-04-28
Days Until
12d
Status
UPCOMING
Analyst
Price Target

Quarterly Results

QuarterRevenueEPS
2026-04-28
2026-03-17$0.65
2026-02-12$0.44
2026-01-23$1.87

FAQ

Baxter International Inc. is a multinational healthcare company headquartered in Deerfield, Illinois, founded in 1931. It provides a broad portfolio of essential medical products and therapies focused on treating chronic and acute conditions in hospital and renal care settings. The company operates through key segments including Medical Products and Therapies, which encompass advanced surgery technologies to enhance surgical techniques, infusion therapies with sterile intravenous solutions, infusion systems and devices, and parenteral nutrition; Healthcare Systems and Technologies, offering smart bed systems, patient monitoring and diagnostic tools, respiratory health devices, and surgical equipment; and Pharmaceuticals, producing inhaled anesthetics and generic injectable pharmaceuticals for pain management, critical care, anti-infection, and oncology. These offerings support acute care, nutritional support, and surgical interventions worldwide, serving healthcare providers with innovative solutions for patient care across Americas, EMEA, and Asia-Pacific regions. Baxter International Inc. plays a vital role in advancing hospital-based care and connectivity solutions.

Earnings & consensus

Next2026-04-28
12dUPCOMING